カテゴリ： GlobalData, スウェーデン, 企業調査

Elekta AB (EKTA B)：医療機器：M&Aディール及び事業提携情報

◆英語タイトル：Elekta AB (EKTA B) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA904C7017
◆発行会社（調査会社）：GlobalData
◆発行日：2018年10月
◆ページ数：78
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：スウェーデン
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Elekta AB (Elekta) is a medical technology company that offers image guided and stereotactic clinical solutions, comprehensive information systems and services for the management of brain disorders and improved cancer care. Its major products include Gamma knife and Extend system; stereotactic system; fully integrated stereotactic radiation therapy system; system for volumetric arc modulated therapy (VMAT); image guided radiation therapy (IGRT) systems; advanced digital treatment systems; treatment planning systems; electronic brachy therapy for skin cancer; and automated remote after loading platform. It also offers oncology information systems for radiation oncology and medical oncology, treatment planning software, cancer registry and soft tissue visualization software, among others. The company operates in North America, Europe, the Middle East, Africa and Asia-Pacific. Elekta is headquartered in Stockholm, Sweden.

Elekta AB (EKTA B) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Elekta AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Elekta AB, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Elekta AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Elekta AB, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Elekta AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Elekta AB, Medical Equipment, Deal Details 12
Asset Purchase 12
Elekta to Acquire Assets of Asesores Electronics Especializados 12
Partnerships 13
Elekta to Enter into Agreement with RTsafe 13
Elekta Enters into Research Agreement with Memorial Sloan Kettering Cancer 14
Elekta Partners with Palabra Apps 15
Elekta to Enter into Agreement with IBA 16
Elekta Enters into Agreement with BrainLAB 17
Elekta Expands Distribution Agreement with Brainlab 18
Elekta Enters into Distribution Agreement with Kobold Medical 19
Elekta Enters into Distribution Agreement with Toshiba Medical Systems for Linear Accelerator 20
Varian Medical Systems Enters Into Integration Agreement With Elekta For VMAT Treatments 21
Philips Enter Into Co-Development Agreement With Elekta And University Medical Center Utrecht 22
Elekta Enters Into Collaboration With Brainlab For Radiosurgery Software 23
Elekta And BrainLAB Enter Into Technology Integration Agreement 24
Elekta Enters Into Agreement With Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital For Cancer Solutions 25
Equity Offering 26
Elekta Announces Private Placement Of Common Stock 26
Debt Offering 27
Elekta Announces Public Offering of Bonds Due 2020 for USD35.3 Million 27
Elekta Announces Public Offering of Floating Rate Bonds Due 2020 for USD82.4 Million 28
Elekta Completes Private Placement Of Convertible Bonds For US$284 Million 29
Asset Transactions 30
York Instruments Acquires MEG Business from Elekta 30
Genesis Care Acquires Portfolio Business from Elekta 31
Elekta to Acquire Assets of Asesores Electronics Especializados 32
Equra Health To Acquire 15 Radiation Therapy Systems And Allied Equipment From Elekta 33
Banner MD Anderson Cancer Center Acquires Multiple Elekta Cancer Management Systems 34
Advanced Radiation Therapy Acquires AccuBoost Assets From Elekta 35
Acquisition 36
Elekta Acquires RTA, Medical Technologies Distributor 36
Elekta Acquires Mesi Medikal, Provider of Radiation Oncology Solutions 37
Elekta Acquires Radon, Linear Accelerator Service Company 38
Elekta AB – Key Competitors 39
Elekta AB – Key Employees 40
Elekta AB – Locations And Subsidiaries 41
Head Office 41
Other Locations & Subsidiaries 41
Recent Developments 44
Strategy And Business Planning 44
Sep 05, 2018: Elekta celebrates inauguration of new global radiotherapy innovation center 44
Jan 31, 2018: Elekta taps IBM Watson Health to bring AI to comprehensive oncology field 45
Jun 22, 2017: Equicare Health and Elekta announce Vendor Interoperability Program partnership 46
Feb 08, 2017: Elekta Partners With ESTRO Cancer Foundation to Increase Radiation Therapy Awareness and Access in Europe 47
Financial Announcements 48
Aug 30, 2018: Elekta: Interim report May-July 2018/19 48
Jun 01, 2018: Elekta: Year-end report May-April 2017/18 49
Mar 02, 2018: Elekta: Interim Report May-January 2017/18 50
Nov 30, 2017: Elekta Announces its Interim report May-October 2017/18 52
Aug 23, 2017: Elekta: Interim Report May-July 2017/18 54
Jun 01, 2017: Elekta: Year-end report May-April 2016/17 55
Mar 01, 2017: Elekta Announces Interim Report May-January 2016/17 57
Corporate Communications 59
Aug 23, 2017: Elekta: Ioannis Panagiotelis appointed as Chief Marketing and Sales Officer 59
Jul 14, 2017: Steven Wort appointed as Elekta’s Chief Operating Officer 60
Jun 01, 2017: Peter Gaccione joins Elekta’s Executive Management as head of North America 61
May 10, 2017: Elekta appoints Gustaf Salford as Chief Financial Officer 62
Legal and Regulatory 63
Apr 03, 2017: Varian Medical Systems and Elekta Settle Patent Litigation 63
Government and Public Interest 64
Feb 03, 2017: Leaders In Cancer Radiotherapy Recognize World Cancer Day Through Elekta Brachytherapy Equipment Donation 64
Product News 65
Sep 18, 2017: Elekta to highlight MOSAIQ Oncology Analytics, a game-changing solution for managing the oncology treatment pathway, at ASTRO Annual Meeting 65
May 26, 2017: Elekta Radiosurgery Solutions Highlighted at International Stereotactic Radiosurgery Society Congress 67
May 02, 2017: Elekta to Showcase the Latest in Stereotactic Solutions at ESTRO 36 68
Other Significant Developments 69
Jul 25, 2018: Elekta Implements PTC’s ThingWorx on Microsoft Azure for Next Generation Remote Service 69
Jul 13, 2018: Elekta to donate advanced radiation therapy machine to Jordan’s Al Bashir Hospital 70
Dec 12, 2017: Elekta and Stockholm County Council agree on constructive way forward 71
Nov 29, 2017: UK’s National Health Service signs GBP 22 million agreement for Elekta cancer treatment systems 72
Nov 21, 2017: 21st Century Oncology chooses Elekta for replacement of radiation therapy devices 73
Oct 02, 2017: Elekta and The Alliance for Cancer Care partner to bring leading-edge radiation therapy and radiosurgery solutions to patients 74
Aug 03, 2017: C-RAD to supply advanced surface tracking solution to Swedish Cancer Center Nya Karolinska Solna 75
Jun 26, 2017: Elekta Chooses Brainlab to Distribute Stereotactic Neurosurgical Solutions Within Selected Markets in Europe 76
Jun 20, 2017: Alliance Cancer Care to Upgrade Cancer Care in Southeastern U.S. with Elekta Solutions 77
Appendix 78
Methodology 78
About GlobalData 78
Contact Us 78
Disclaimer 78

List of Tables
Elekta AB, Medical Equipment, Key Facts, 2018 2
Elekta AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Elekta AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Elekta AB, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Elekta AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Elekta AB, Deals By Market, 2012 to YTD 2018 9
Elekta AB, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Elekta to Acquire Assets of Asesores Electronics Especializados 12
Elekta to Enter into Agreement with RTsafe 13
Elekta Enters into Research Agreement with Memorial Sloan Kettering Cancer 14
Elekta Partners with Palabra Apps 15
Elekta to Enter into Agreement with IBA 16
Elekta Enters into Agreement with BrainLAB 17
Elekta Expands Distribution Agreement with Brainlab 18
Elekta Enters into Distribution Agreement with Kobold Medical 19
Elekta Enters into Distribution Agreement with Toshiba Medical Systems for Linear Accelerator 20
Varian Medical Systems Enters Into Integration Agreement With Elekta For VMAT Treatments 21
Philips Enter Into Co-Development Agreement With Elekta And University Medical Center Utrecht 22
Elekta Enters Into Collaboration With Brainlab For Radiosurgery Software 23
Elekta And BrainLAB Enter Into Technology Integration Agreement 24
Elekta Enters Into Agreement With Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital For Cancer Solutions 25
Elekta Announces Private Placement Of Common Stock 26
Elekta Announces Public Offering of Bonds Due 2020 for USD35.3 Million 27
Elekta Announces Public Offering of Floating Rate Bonds Due 2020 for USD82.4 Million 28
Elekta Completes Private Placement Of Convertible Bonds For US$284 Million 29
York Instruments Acquires MEG Business from Elekta 30
Genesis Care Acquires Portfolio Business from Elekta 31
Elekta to Acquire Assets of Asesores Electronics Especializados 32
Equra Health To Acquire 15 Radiation Therapy Systems And Allied Equipment From Elekta 33
Banner MD Anderson Cancer Center Acquires Multiple Elekta Cancer Management Systems 34
Advanced Radiation Therapy Acquires AccuBoost Assets From Elekta 35
Elekta Acquires RTA, Medical Technologies Distributor 36
Elekta Acquires Mesi Medikal, Provider of Radiation Oncology Solutions 37
Elekta Acquires Radon, Linear Accelerator Service Company 38
Elekta AB, Key Competitors 39
Elekta AB, Key Employees 40
Elekta AB, Other Locations 41
Elekta AB, Subsidiaries 41

List of Figures
Elekta AB, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Elekta AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Elekta AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Elekta AB, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Elekta AB, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Elekta AB, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Elekta AB, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Elekta AB, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Elekta AB (EKTA B)：医療機器：M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Civitas Solutions Inc：企業の戦略・SWOT・財務情報
    Civitas Solutions Inc - Strategy, SWOT and Corporate Finance Report Summary Civitas Solutions Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Fusion Telecommunications International, Inc.：企業のM&A・事業提携・投資動向
    Fusion Telecommunications International, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Fusion Telecommunications International, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, …
  • MTS Systems Corp (MTSC)：企業の財務・戦略的SWOT分析
    Summary MTS Systems Corp (MTS) is an industrial equipment supplier that offers testing and sensing solutions. The company’s products include test components, actuators and hydraulic components, controllers, grips, fixtures and accessories, hydraulic power and distribution; environmental simulation s …
  • Carl Zeiss Meditec AG (AFX)：医療機器：M&Aディール及び事業提携情報
    Summary Carl Zeiss Meditec AG (Carl Zeiss Meditec), a division of Carl Zeiss AG, is an integrated medical technology company, which provides visualization solutions for minimally invasive surgical treatments. It operates in the fields of ophthalmology, neuro/ENT surgery and surgical ophthalmology. T …
  • PH&T SpA-製薬・医療分野：企業M&A・提携分析
    Summary PH&T SpA (PH&T), a subsidiary of Wise SGR SpA is a pharmaceutical company that conducts research activities. The company carries out research, development and manufacturing of generic drugs for specialist therapies, medical devices and nutraceuticals. It provides difficult to formulate presc …
  • Biocare Medical LLC-医療機器分野：企業M&A・提携分析
    Summary Biocare Medical LLC (Biocare) develops and supplies automated immunohistochemistry instrumentation and reagents. The company offers androgen receptor, amyloid A, estrogen receptor, ERG, factor xlla and folate receptor alpha IHC assay kit, among others. It offers on-site training, technical s …
  • Commercial Bank of Dubai PSC：企業の戦略・SWOT・財務情報
    Commercial Bank of Dubai PSC - Strategy, SWOT and Corporate Finance Report Summary Commercial Bank of Dubai PSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • SOCO International plc (SIA)：企業の財務・戦略的SWOT分析
    Summary SOCO International Plc (SOCO) is an oil and gas company that explores, discovers and produces oil and gas reserves. The company offers appraisal and field development services. It provides training and skills and support local communities. SOCO produces and supplies natural resources. SOCO h …
  • Diagnostics For All Inc：企業の製品パイプライン分析2018
    Summary Diagnostics For All Inc (DFA) is a drug development company that develops and commercializes of new technology and practical diagnostic devices for diagnostic companies. The company uses patterned paper technology to create electrochemical clinical chemistry assays, immunoassays, assays, and …
  • Meridian Energy Limited：企業の戦略・SWOT・財務分析
    Meridian Energy Limited - Strategy, SWOT and Corporate Finance Report Summary Meridian Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Mead Johnson Nutrition Company：企業の戦略・SWOT・財務情報
    Mead Johnson Nutrition Company - Strategy, SWOT and Corporate Finance Report Summary Mead Johnson Nutrition Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Hexcel Corp (HXL)：企業の財務・戦略的SWOT分析
    Hexcel Corp (HXL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • iTeos Therapeutics SA：製薬・医療：M&Aディール及び事業提携情報
    Summary iTeos Therapeutics SA (iTeos) is a biotechnology company that develops novel cancer immunotherapies. The company’s pipeline products include small molecule immunomodulators targeting IDO1, A2A, immune check points, STING agonist, and antibodies directed to TIGIT and Galectin 3. It also devel …
  • Bank Sepah：企業の戦略・SWOT・財務情報
    Bank Sepah - Strategy, SWOT and Corporate Finance Report Summary Bank Sepah - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Nissan Chemical Corp (4021)：企業の財務・戦略的SWOT分析
    Nissan Chemical Corp (4021) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Echo Therapeutics Inc (ECTE)-医療機器分野：企業M&A・提携分析
    Summary Echo Therapeutics Inc (Echo Therapeutics) is a medical device and a specialty pharmaceutical company, which develops wireless continuous glucose monitoring (CGM) system. Its product portfolio includes Continuous Glucose Monitoring, which is a CGM System, a skin preparation device, transderma …
  • T-Mobile US, Inc.：企業の戦略・SWOT・財務情報
    T-Mobile US, Inc. - Strategy, SWOT and Corporate Finance Report Summary T-Mobile US, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Jamaica Public Service Co Ltd：企業の発電所・SWOT分析2018
    Jamaica Public Service Co Ltd - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Distilleries Company of Sri Lanka PLC：戦略・SWOT・企業財務分析
    Distilleries Company of Sri Lanka PLC - Strategy, SWOT and Corporate Finance Report Summary Distilleries Company of Sri Lanka PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Toppan Printing Co Ltd：企業の戦略・SWOT・財務情報
    Toppan Printing Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Toppan Printing Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆